- Generic name
- Ondansetron
- Strength
- 16 mg
- Dosage form
- Suppository
- Manufactured by
- Square Pharmaceuticals PLC.
Ofran Suppository
About Ofran 16 mg Suppository
Ofran 16 mg Suppository is a rectal medicine containing ondansetron, used to prevent nausea and vomiting linked to cancer chemotherapy or radiotherapy and after surgery. It is made by Square Pharmaceuticals PLC.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Ofran 16 mg Suppository?
Ofran 16 mg Suppository is a rectal form of ondansetron, a medicine that blocks a specific receptor in the body involved in triggering the vomiting reflex. It is used to help prevent nausea and vomiting that can occur with cancer chemotherapy or radiotherapy, and to prevent and treat nausea and vomiting after surgery. The suppository is placed into the rectum. The doctor decides the dose and how long it should be used, based on the person's condition and treatment plan. This medicine is not for self-treatment; it should be used under medical supervision.
Uses of Ofran
Ofran 16 mg Suppository is used to prevent nausea and vomiting caused by initial and repeat courses of cancer chemotherapy. It is also used to prevent nausea and vomiting from radiotherapy and to prevent and treat nausea and vomiting after surgery. The doctor decides when it is appropriate and how it should be used as part of the overall treatment plan.
How to use Ofran
Ofran 16 mg Suppository is placed into the rectum as directed by the doctor. The dose and the number of doses are decided by the doctor based on the reason it is being used and the person's condition. Do not change the dose or stop using it without talking to the doctor. If you are unsure how to use a suppository, ask your doctor or pharmacist for instructions.
Side effects of Ofran
Common side effects include headache, constipation, and diarrhoea, but most are mild or moderate. Rash has been reported in some patients receiving ondansetron for chemotherapy-induced nausea and vomiting. Other reported effects include a feeling of flushing or warmth, hiccups, and changes in liver enzymes. Rarely, serious allergic reactions, breathing problems, fast heartbeat, chest pain, and low potassium have been reported. Tell your doctor if you notice any side effect.
Safety and precautions
Tell your doctor if you are allergic to ondansetron or similar medicines. This medicine is not a substitute for stomach suction and should not be used instead of it. After abdominal surgery or during chemotherapy, it may hide signs of bowel problems, so your doctor will monitor you. There are no adequate studies in pregnant women; the doctor will decide if it can be used during pregnancy. It is not known if ondansetron passes into breast milk, so ask your doctor before breastfeeding. Ask your doctor first if you have liver problems or other health conditions.
Frequently asked questions
How should Ofran 16 mg Suppository be taken?
It is placed into the rectum. The doctor decides the dose, how often it is used, and how long the course lasts, based on your condition and treatment. Do not change the dose yourself. If you are unsure how to use a suppository, ask your doctor or pharmacist.
What is Ofran 16 mg Suppository used for and what kind of medicine is it?
It is an anti-emetic medicine containing ondansetron. It is used to prevent nausea and vomiting from cancer chemotherapy or radiotherapy and to prevent and treat nausea and vomiting after surgery. The doctor decides if it is suitable for you.
Is Ofran 16 mg Suppository safe in pregnancy or breastfeeding?
There are no adequate and well-controlled studies in pregnant women, so the doctor will decide if it can be used during pregnancy. It is not known if ondansetron passes into breast milk. Ask your doctor before using it if you are pregnant, planning pregnancy, or breastfeeding.
Can I use Ofran 16 mg Suppository without a doctor's advice?
No, it should be used only under medical supervision. The doctor decides the dose and course. Do not self-medicate. Tell your doctor about any allergies or other medicines you take before using it.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.